passive immunization polyclonal antibody pabs purified animal serum first adopted treat diphtheria 19th century graham ambrosino antibiotic monoclonal antibody progressively substituted antiserum based therapy however pabs based antivenoms remain available treatment complex toxin mixture present snake venom global venom burden estimated million envenomings death per year chippaux despite steady improvement gutierrez gutierrez antivenom based snakebite treatment free side effect consequence exposure heterologous antibody constant region furthermore antivenom supply constant risk due high manufacturing cost low income level target population arnold harrison antivenoms made recombinant human humanized antibody cocktail would highly desirable alternative would reduce adverse effect facilitating product standardization reproducibility unfortunately manufacturing cost complex antibody cocktail still high ensure consistency often require parallel production line component cocktail conversely simplifying cocktail composition may compromise efficacy due high diversity toxin comprising venom furthermore difficult reconcile move towards cocktail simplification major trend antivenom formulation namely widen spectrum snake venom covered single treatment lavonas stock overcome limitation developed synthetic biology strategy antivenom production based expression recombinant pabs plant plant biofactories provide affordable alternative platform recombinant antibody production usually known plantibodies stoger due scalability high production yield low risk contamination adventitious pathogen lower requirement production facility building paul paul proposed strategy us plant chassis production platform take advantage intrinsic property many plant virus known superinfection exclusion ensure reproducibility prevents superinfection cell second virus already infected closely related resident virus julve soller epstein syller important consequence fact population variant plant virus infection uniformly distributed structured mosaic like pattern importantly distribution ensures maintenance propagation population diversity compared fitness driven quasispecies like distribution typical unstructured population dynamic elena investigated use virus based expression system induction somatic expression mosaic plant leaf tile mosaic function independent monoclonal micro production line together leading production recombinant polyclonal cocktail study show strategy ensures simultaneous production high yield recombinant pabs comprising hundred idiotypes outstanding batch batch reproducibility independently complexity polyclonal composition importantly show novel strategy enables expression selected portion mammalian immunized antibody repertoire transiently multitransgenic plant highly reproducible manner also show strategy used synthetize complex plant made antibody cocktail able neutralize wide range toxin venom medically important snake central america gutierrez thus opening door formulation efficient affordable plant made recombinant antivenoms characterization somatic expression mosaic spatio temporal dynamic mosaic like expression pattern monitored leaf agroinfiltration three virus based infective clone encoding gfp bfp dsred fluorescent protein figure better understand dynamic mosaic formation created computer simulation netlogo see figure compared predicted computer output experimental mosaic pattern obtained simultaneous agroinfiltration three viral clone encoding fluorescent protein based computer simulation anticipated given set initial parameter mosaic colour composition would highly reproducible outcome figure reproducibility would increase number initial infection focus time course infiltration analysis experimentally corroborated prediction figure observation hypothesized mosaic distribution pattern viral clone imposed offer competition limited microenvironment ensures survival low fitness clone moreover sufficiently high initial number infective focus also protect system fluctuation population dynamic providing highly reproducible outcome principle superinfection exclusion leaf showing somatic expression mosaic produced three magnicon viral clone encoding dsred green blue florescent protein agroinfected simultaneously mosaic observed either red green filter dsred left light right detail mosaic framed leaf area netlogo computer simulation triple viral infection red green blue subjected virtual area comprising virtual cell virtual fitness clone adjusted virtual adjusted upper image lower image arbitrary unit match natural infection see method detailed definition repeated netlogo simulation evolution triple infection using value respectively experimental data evolution triple infection leaf performed two different recorded daily day postinfiltration evolution clone expansion represented percentage total leaf area occupied clone testing expression mosaic production recombinant pabs pluribody technology case study multiprotein plant biofactory attempted determine whether platform could produce high yield recombinant antibody mix preserving diversity composition ensuring high batch batch reproducibility yielding final product functionally equivalent traditional animal antivenom ass diversity preservation first assayed expression antibody library obtained camel peripheral mononuclear blood cell pmbc comprising fraction antibody repertoire present circulating cell individual dromedary camel camel antibody preferred camelids display large immune repertoire single chain antibody format hcab feature greatly simplifies library construction subsequent production plant using viral vector hcab variable antibody region pcr amplified pmbc cdna cloned pgvh vector modified version tobacco mosaic virus tmv derived binary magnicon vector containing frame histidine tag detection figure pgvh library mobilized cell leaf using vacuum agroinfiltration day incubation leaf apoplast fluid recovered detached leaf purified affinity chromatography resulting purified protein band expected average size kda figure anticipated two dimensional electrophoretic separation resolved underlying protein complexity revealed pattern distinguishable spot indicative polyclonal nature sample figure resulting plant made multiple recombinant antibody product hereafter referred pluribody sample estimate size repertoire expressed using system gfp clone infiltrated together pgvh library different ratio calculated one gram fresh leaf produce expression tile using library inoculum figure assessment antiserum diversity schema cloning transient expression procedure used production polyclonal antibody first second dimension electrophoresis separation clone purified leaf using affinity column expression clone viral subpopulation within library image taken dpi average tile size recorded used estimate tile density dependence right attb site specific recombination site signal peptide nontranslated region tnos terminator nopaline synthase pluribody technology ensures batch batch reproducibility investigated ability system reproduce composition reactivity mammalian immune subrepertoires end new antibody library pgvh constructed starting pbmc sample obtained three dromedary camel immunized venom cocktail derived three snake specie favour reproducibility ensure preservation original diversity subsequent analysis library construction procedure standardized shown detailed method working cell bank wcb aliquot first used evaluate production strategy term reproducibility comparing different pluribody preparation first three pluribody sample derived immune repertoire prepared different wcbs pim_1 pim_2 pim_3 labelled different fluorophores resolved dige analysis almost perfect overlapping dige image indicated three complex protein sample remarkably similar figure separate dige experiment two immune pluribodies pim_1 pim_2 compared third preparation derived nonimmune repertoire ppi_1 corresponding similarity plot show figure comparison protein spot equivalent immune pluribody sample pim_1 pim_2 produced narrowly centred volume ratio distribution indicative highly reproducible composition contrast comparison sample derived different immune repertoire ppi_1 pim_1 ppi_1 pim_2 showed clear deviation volume ratio furthermore deep sequencing cdr3 region mrna agroinfiltrated plant showed remarkable conservation sequence distribution equivalent sample ppi1 ppi2 pim1 pim2 minor difference observed abundant cdr3 sequence figure finally venom binding activity ppi pim sample compared immune pluribodies consistently showed reactivity three venom employed immunization figure binding activity observed bsa nonrelated venom figure assessment pluribody reproducibility individual merged image three independent hyperimmune pluribody preparation format comparison relative abundance individual antibody clone plant sample agroinfiltrated inoculum independent derived antibody clone identified deep sequencing region correspond equivalent pre immune correspond equivalent immune polyclonal comparison colour correspond identical antibody clone comparison purified pluribody preparation centred dot represent volume ratio close one test showing venom binding activity three nonequivalent preparation obtained different individual camel analysed three venom employed immunization specificity test venom binding comparing reactivity cobra venom formulation snake plantivenom using pluribody technology contrast traditional antivenoms obtained hyperimmune animal plasma pluribodies derive pmbc pool hence genetic information retrieved corresponds minor fraction reactive cell made circulating memory cell way bone marrow therefore order create functional plant made antivenom hereafter termed plantivenom decided enrich pluribody repertoire toxin binder introducing intermediate selection step production flow chart see pcr amplified immune subrepertoires first cloned phage display vector subjected three successive round selection venom maximize diversity avoid dominant single antigen selection bias phage panning conducted different fraction venom four total roughly corresponding group toxin activity figure selection four sublibraries pooled variable antibody region amplified transferred bulk pgvh_iggh1 vector figure carrying constant region human iggh1 create enriched polyclonal master cell bank mcb increased reactivity potentially le likely produce hypersensitivity reaction ep_mcb subsequently distributed wcbs agroinfiltrated pep_1 formulation showed 2xlog increase total binding activity compared nonenriched pluribody elisa figure demonstrating enrichment polyclonal composition obtained selection successfully transferred plant globally reproduce reactivity gain finally order produce first iteration plantivenom candidate decided produce pluribody incorporating individual clone showed maximum binding activity clone composition resulting enriched oligoclonal formulation eo_1 see detailed information table eo_wcb employed scale antibody production using one kilogram agroinfiltrated leaf yielding recombinant polyclonal antibody collected corresponding leaf apoplastic fluid following affinity purification figure antivenom solution pb peo_1 prepared concentration protein similar typical concentration equivalent commercial antivenoms used characterization summarized table expected peo_1 solution showed enriched antivenom binding activity assayed elisa venom figure figure showed phospholipases pla lesser extent serine proteinase iii snake venom metalloproteinases svmp amino acid oxidase lao molecule efficiently retained immobilized plantivenom however affinity matrix poor capturing disintegrins disi pattern immunorecognition mirror immunological profile monospecific antivenoms gutierrez shown quantitatively immunocapture iii svmps serine proteinase amino acid oxidase lesser extent medium sized disintegrins pla molecule serine proteinase svmp bap1 later ability peo_1 neutralize different toxic enzymatic activity analysed peo_1 plantivenom able neutralize venom haemorrhagic pla proteinase lethal activity table figure illustrates neutralization haemorrhagic activity mouse skin test plantivenom neutralize coagulant activity plasma maximum concentration tested plantivenom venom table finally tested capacity peo_1 neutralize lethality induced venom mouse using lds venom challenge dose peo_1 prevented lethality injected mouse ratio plantivenom venom supporting information estimated median effective dose plantivenom venom confidence limit table peo_1 neutralization activity assayed parallel commercial horse derived antivenom corresponding neutralizing activity also summarized table horse derived antivenom effective neutralization enzymatic toxic effect assayed strategy pluribody formulation enrichment chromatographic profile electrophoresis separation venom employed antivenom pluribody enrichment showing four group toxin employed phage display selection reduce antigen drift cloning procedure variable region derived psword phage display vector binary vector plant expression adapted magnicon deconstructed system assessment plantivenom functionality coomassie gel enriched oligoclonal plantivenom production purification step lane1 crude apoplastic fluid lane leaf crude extract lane control apoplastic fluid uninfected leaf lane clarified apoplastic fluid lane protein flow line first wash lane eluted plantivenom comparison binding activity venom sequential plantivenom enrichment step pre immune plantivenom immune plantivenom enriched polyclonal plantivenom derived second third phage display selection round comparison binding activity antivenomic profile plantivenom upper lower panel display respectively chromatographic profile whole costa rican pacific population venom venom fraction nonimmunoretained immobilized affinity column neutralization venom haemorrhagic activity plantivenom preparation protein figure show abdominal surface mouse skin injection constant dose full venom different amount plantivenom haemorrhagic spot appearing mouse injected intradermally venom inhibition haemorrhagic spot antivenom dose venom venom venom negative control plantivenom diluted neutralization toxic activity venom plantivenom equine derived antivenom border bottom solid 1px toxic enzymatic activity venom equine derived venom neutralization haemorrhagic phospholipase proteinase lethal activity expressed median effective dose whereas neutralization vitro coagulant activity expressed effective dose term plantivenom antivenom venom protein see detail result presented mean neutralization haemorrhagic phospholipase proteinase coagulant effect case neutralization lethal effect confidence limit included parenthesis global antivenom shortage prompted several line research aimed finding solution main production bottleneck use immunization dna recombinant expressed epitope relevant toxin example aimed circumventing shortage antigen specie low venom yield coral snake ramos comparison fully recombinant strategy provide satisfactory solution long term addressing shortage antigen also problem arising current therapy adverse reaction reproducibility laustsen theory rationally designed cocktail formulation made recombinant mabs could outperform animal plasma derived antivenoms composition latter comprises large fraction immunologically irrelevant antitoxin antibody contrast adjusting antivenom composition minimal number selected functional component safety profile improved manufacturing cost reduced minimal recombinant antibody cocktail comprising three mabs antibody main toxin shown neutralize lethal toxicity venom frauches indicating oligoclonal cocktail suitable antivenom formulation least case notwithstanding potent cocktail would probably require complex combination incorporating antibody minor toxin could act alone synergistically toxin ensure coverage intra interspecific variation complex cocktail composition imposes serious constraint current manufacturing system indeed whereas formulation improved cocktail seems accessible objective current antibody selection technique lack suitable production system combination proved practical limitation discouraging advance pluribody strategy line recent strategy based mammalian cell culture aimed produce affordable antibody cocktail laustsen rasmussen foster development improved recombinant formulation employ plant virus based expression system offer advantage associated use plant biofactories example deconstructed virus strategy marillonnet successfully used produce mapp anti ebola protective antibody cocktail qiu among example record yield anti idiotype antibody reported using magnicon bendandi current nonoptimized yield sqm greenhouse facility growing biomass year walwyn could produce gram dos per year improvement yield formulation could reach dos year reasonable scenario synthetic diversity offered somatic mosaicism exploited quickly transfer large immune mammalian subrepertoires exemplified pim formulation although faithful reproduction mammalian repertoire cannot guaranteed shown antivenom binding profile large plant made repertoire largely resemble corresponding antiserum occurs successive enrichment step indicating possible expression bias affect substantially binding profile final product future sampling lymphoid organ cell sorting procedure could incorporated enrich composition polyclonal mixture alternatively additional selection step shown used refine composition producing optimized oligoclonal mixture line decision conduct final efficacy test oligoclonal formulation taken double objective first maximize diversity antigen late phage display round could end selecting strong monoclonal binder second facilitate dissection neutralization result individual characterization antibody cocktail facilitate improvement subsequent formulation via incorporation new distinct individual clone peo_1 cocktail described showed reasonable spectrum neutralizing activity relatively little effort antibody selection however effort required reach efficacy level current commercial antivenoms envenomings characterized several pathological pathophysiological alteration among alteration coagulation important thus antivenom considered use envenomings able neutralize coagulant effect venom prompt effort increase neutralizing capacity plantivenom generate neutralization coagulant activity consistency reproducibility ensured pluribody strategy opportunity formulation improvement implementation successive design build test cycle manifold neutralization coagulant activity improved introduction new serine protease neutralizing clone improved antibody selection procedure synthetic repertoire alternative single cell selection method beerli rader streamlined formulation also involve elimination clone overlapping non neutralizing activity ultimately incorporation neutralizing activity snake venom region result followed depth preclinical assessment plantivenom using various animal model plantivenom capacity neutralize toxic activity venom developed next step would consider implementation clinical trial stablish clinical dos dose antivenom administered clinical case cannot directly extrapolated preclinical neutralization test roughly estimated adult specimen may inject venom bite although varies bite bite according many variable size snake volume venom available gland strength bite etc antivenom demonstrated efficacy preclinical test clinical trial involve initial dose finding phase optimal dose antivenom selected dose used extensive clinical trial higher number patient manipulation manufacturing purpose pivotal pluribody approach ensures independence micro production line resulting highly reproducible final product resulting structured population distribution simplifies modelling production process whole system regarded sum thousand independent micro production line expression tile working parallel work also underscore potential plant synthetic biology offer world new bio fabrication solution pluribody technology combine genetic element biological source distant camel human plant virus capture immune repertoire hyperimmunized camel recapitulate within plant chassis creating plantivenoms able neutralize wide range toxin activity provide protection lethal venom dos mouse beyond antivenoms believe ability formulate pluribodies could provide new boost passive immunotherapy facilitating formulation manufacturing new affordable antitoxin antimicrobial product detailed information experimental method found procedure involving experimental mouse meet requirement guiding principle biomedical research involving animal cioms approved institutional committee care use laboratory animal universidad costa rica approval number camel immunization protocol followed animal experimentation guideline published regional government canary island spain approved ethic committee veterinary medicine service la palmas gran canaria university foundation ref snake venom venom fraction venom obtained specimen serpentarium instituto clodomiro picado university costa rica san jos√© venom fractionation venom protein separated reverse phase hplc resolved chromatographic peak collected separately eluted fraction pooled four group group mainly composed disintegrins group phospholipases group mainly contained serine protease pla2 group enriched metalloproteinases camel immunization total rna isolation amplification sequence three camel immunized cocktail containing equal amount three snake venom peripheral blood lymphocyte pbls obtained pre immune immune sample used isolate rna synthesize cdna used template pcr amplification coding sequence see material method table list primer used phage display library construction selection amplified sequence directly cloned pcr product psword phagemid vector ligation product transformed first round venom binder selected using full venom antigen subsequent selection round carried separately one four antigen group obtained venom fractionation monitoring library enrichment carried polyclonal phage elisa full venom monoclonal phage elisa carried way individual clone third round selection clone showing highest binding affinity individual antigen selected formulate oligoclonal mix two clone group eight group six group group sequence amplified pbl cdna directly cloned pcr product pgvh selected phage display library individual clone cloned pgvh igg vector pgvh pgvh igg adaptation magnicon plant viral expression vector pich7410 icon genetics built pdgb1 vector backbone sarrion perdigones ligation product transformed cell plated solid agar plate library bacteria scraped stored aliquot library stock one tenth library used plasmid dna isolation individual clone single colony used inoculate fresh culture afterwards used plasmid dna isolation remaining culture stored aliquot glycerol stock isolated plasmid dna transformed gv3101 strain transformation spread plate bacteria scraped stored aliquot library stock create master cell bank mcb mcb aliquot grown distributed working cell bank wcb used agroinfiltration estimation polyclonal diversity somatic mosaic determine average tile size typical polyclonal experiment pgvh antibody library mixed pggfp clone different ratio infiltrated different od600s leaf image experimental point taken day analysed imagej software number tile average tile size calculated using analyse particle function experimental surface weight conversion rate leaf applied calculate number expression tile per biomass polyclonal oligoclonal agroinfiltrations aliquot wcb collection used inoculate appropriate volume supplemented antibiotic subculture culture grown culture collected centrifugation min suspended agroinfiltration medium me mgcl acetosyringone optical density incubated room temperature horizontal rolling mixer infiltration bacterial suspension harbouring 6xhis provector module mixed equal volume pich14011 integrase pich17388 provector module suspension agroinfiltration week old plant submerged agroinfiltration solution vacuum applied pressure bar vacuum degassing chamber dp118 applied vacuum engineering thornbury held min slowly released sample protein extraction collected day postinfiltration analysis diversity reproducibility dna level http nbc11 biologie uni http nbc11 biologie uni sequencing library prepared 6xhis immune pre immune library agroinfiltrated leaf see material method table list primer used library sequenced ion torrent pgm life sequencing valencia spain sequence quality trimming novo assembly posterior analysis conducted using custom python script iassembler software zheng unigenes composed least two member used library comparison blastn using blast user tool computer simulation somatic expression mosaic http pgb ibmcp csic netlogo netlogo html http pgb ibmcp csic netlogo netlogo html simulation expression mosaic formation performed netlogo agent based modelling software wilensky script designed simulate cell cell movement exclusion enabled viral clone two dimensional hexagonal grid wilensky affinity chromatography based antivenomic pla employed address immunocapturing ability peo_1 towards venom component column prepared immobilizing plantivenom cyanogen bromide activated sepharose sigma louis usa following manufacturer instruction column loaded venom pooled specimen pacific versant costa rica bound nonretained fraction analysed hplc chromatographic run whole venom dissolved pb used control neutralization toxic activity ability plantivenom neutralize proteinase phospholipase pla2 hemorrhagic coagulant lethal activity determined previously described bolanos gene gutierrez gutierrez gutierrez theakston reid wang neutralization expressed median effective dose lethal haemorrhagic proteinase pla activity plantivenom venom equine antivenom venom ratio effect inhibited segura effective dose coagulant activity plantivenom venom equine antivenom venom ratio clotting time prolonged three time compared venom incubated pb instead antibody gene schema production different pluribody formulation representing camel antibody subrepertoires characterization individual clone comprising peo_1 plantivenom binding activity venom compared bsa shown next amino acid sequence primer used vhh cloning generation sequencing library click additional data file